Published in Biomaterials on December 02, 2015
Post-nano strategies for drug delivery: Multistage porous silicon microvectors. J Mater Chem B Mater Biol Med (2016) 0.75
The Emerging Role of Nanotechnology in Cell and Organ Transplantation. Transplantation (2016) 0.75
Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability. Sci Rep (2016) 0.75
Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature (2007) 7.21
Role of CD47 as a marker of self on red blood cells. Science (2000) 7.00
Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater (2011) 3.83
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol (2008) 3.78
LC3 and Autophagy. Methods Mol Biol (2008) 3.59
Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc Natl Acad Sci U S A (2011) 2.63
The NF-kappaB regulatory network. Cardiovasc Toxicol (2006) 2.25
Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol (2012) 1.85
The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol (2002) 1.79
Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release (2011) 1.72
Tailored porous silicon microparticles: fabrication and properties. Chemphyschem (2010) 1.71
Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors. AIP Adv (2012) 1.35
Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation. Methods Enzymol (2009) 1.24
NF-κB signaling pathway and free radical impact. Acta Biochim Pol (2012) 1.09
Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics. Biomaterials (2013) 1.03
Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions. J Leukoc Biol (2006) 1.02
Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors. Small (2012) 0.95
Modeling of nanotherapeutics delivery based on tumor perfusion. New J Phys (2013) 0.94
Tuning the autophagy-inducing activity of lanthanide-based nanocrystals through specific surface-coating peptides. Nat Mater (2012) 0.93
Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer. Eur J Cancer (2013) 0.90
Degradation and biocompatibility of multistage nanovectors in physiological systems. J Biomed Mater Res A (2013) 0.90
Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy. Adv Healthc Mater (2014) 0.87
Evaluation of cell function upon nanovector internalization. Small (2012) 0.87
Real-time intravital microscopy of individual nanoparticle dynamics in liver and tumors of live mice. Protoc exch (2013) 0.87
Bromelain surface modification increases the diffusion of silica nanoparticles in the tumor extracellular matrix. ACS Nano (2014) 0.86
Multistage vector (MSV) therapeutics. J Control Release (2015) 0.84
Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications. Chin Sci Bull (2012) 0.83
Proteomic Profiling of a Biomimetic Drug Delivery Platform. Curr Drug Targets (2015) 0.83
The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation. Biomaterials (2014) 0.82
Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. Curr Drug Targets (2015) 0.80
Inflammation and skeletal metastasis. Bonekey Rep (2015) 0.79
Removal of Small Fragments of Nucleic Acid from Preparations of Plasmid DNA by Centrifugation through NaCl. CSH Protoc (2006) 0.77
Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response. Cell Rep (2015) 0.82
Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials. Nanomedicine (Lond) (2015) 0.79
A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells. Pharmacol Res (2016) 0.78
Multistage vector delivery of sulindac and silymarin for prevention of colon cancer. Colloids Surf B Biointerfaces (2015) 0.77